Brevan Howard Capital Management LP Sage Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 19,901 shares of SAGE stock, worth $211,348. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,901
Previous 21,267
6.42%
Holding current value
$211,348
Previous $460,000
19.13%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$61.1 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$58.2 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$47.7 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $631M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...